Key Segmentation:
By Offering
-
Software/Platforms
-
Services
By Technology
-
Structure Prediction & Modeling
-
De Novo Protein Generation
-
Directed Evolution & Sequence Optimization
-
Protein-Protein Interaction Modeling
By Application
-
Drug Discovery & Therapeutics
-
Industrial Enzymes & Biomanufacturing
-
Agriculture & Agritech
-
Vaccine & Diagnostics Development
By End User
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
CROs & CDMOs
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Technology X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the AI Protein Design Market include Isomorphic Labs, Xaira Therapeutics, Inc., Chai Discovery, Inc., Generate:Biomedicines, Inc., Absci Corporation, Recursion Pharmaceuticals, Inc., Insilico Medicine, Inc., EvolutionaryScale PBC, Profluent Bio, Inc., and others.
Key opportunities include expansion into industrial biotechnology, AI-designed enzyme engineering, multimodal foundation models, closed-loop design-build-test-validate platforms, and growing pharmaceutical investment in generative biology.
The market is driven by rapid integration of generative AI into pharmaceutical discovery and industrial enzyme engineering, rising pharma-biotech partnership activity, and continued advancement in structure prediction and de novo generation model accuracy.
The Drug Discovery & Therapeutics segment dominated the AI Protein Design Market in 2025, accounting for approximately 59.30% market share.
The North America region dominated the AI Protein Design Market in 2025 with a 39.60% share, driven by dense concentration of AI-native biotechnology platforms and deep pharmaceutical R&D investment.
Asia Pacific is expected to register the fastest CAGR of 28.30% during the forecast period 2026-2035.
